| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/13/2001 | US6200799 Replication-defective recombinant virus includes promoter from human major intrinsic protein or human crystallin and an open reading frame of human ras, herpes simplex type i thymidine kinase, or non-phosphorylatable retinoblastoma |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200565 Oral administration of immunoglobulins for treating autoimmune hearing loss |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016164A2 Treatment of allergic rhinitis |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001015721A1 Novel uses of semaphorin and vegf |
| 03/08/2001 | WO2001015719A2 Treatment of conjunctivitis |
| 03/08/2001 | WO2001015707A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | WO2001015677A2 Use of 5-ht1b/1d agonists to treat otic pain |
| 03/08/2001 | WO2001015531A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/08/2001 | WO2000066139A3 Biochemical methods that eliminate corneal scars, opacification and haze |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382570A1 Treatment of allergic rhinitis |
| 03/08/2001 | CA2382473A1 Treatment of conjunctivitis |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382303A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081135A2 1H-indole-3-glyoxylamide spla2 inhibitors |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080074A1 New heterocyclically substituted amides, their production and their use |
| 03/07/2001 | EP1080070A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079792A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 03/07/2001 | EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders |
| 03/07/2001 | EP0847276B1 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/07/2001 | CN1286084A Injection for cataract operation and treating glaucoma |
| 03/07/2001 | CN1062869C Prednisolone derivs |
| 03/07/2001 | CN1062762C Medicinal composition for treatment of myopia and amblyopia, and preparation method thereof |
| 03/07/2001 | CN1062753C Medicine for preventing and treating eye diseases |
| 03/06/2001 | US6197959 Piperidine derivatives |
| 03/06/2001 | US6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197760 Isophosphoramide mustard analogs and use thereof |
| 03/06/2001 | US6197300 ftsZ |
| 03/01/2001 | WO2001014570A1 Activatable recombinant neurotoxins |
| 03/01/2001 | WO2001014405A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | WO2001014402A1 Antisense modulation of focal adhesion kinase expression |
| 03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001013916A1 Drugs inhibiting cell death |
| 03/01/2001 | WO2001013911A1 Agents inhibiting hypertensive arteriolar disorder |
| 03/01/2001 | WO2001013901A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 03/01/2001 | WO2000078297A3 Stable xylometazoline and oxymetazoline solution |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO1998042379A3 Chemically and thermally stable norastemizole formulations |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2380457A1 Activatable recombinant neurotoxins |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 02/28/2001 | EP1078633A2 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 02/28/2001 | EP1078629A2 Use of Salmeterol and salts for the treatment of inflammation and allergy |
| 02/28/2001 | EP1078002A1 Peptide antiangiogenic drugs |
| 02/28/2001 | EP1077995A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
| 02/28/2001 | CN1285828A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/28/2001 | CN1285211A Formula of medicine for treating myopia and preparation process thereof |
| 02/27/2001 | US6194462 Pharmaceutical preparation containing nimesulide for oral administration |
| 02/27/2001 | US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions |
| 02/27/2001 | US6194457 Liquid eye drop composition |
| 02/27/2001 | US6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof |
| 02/27/2001 | US6194449 Allosteric adenosine receptor modulators |
| 02/27/2001 | US6194431 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 02/27/2001 | US6194415 Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| 02/27/2001 | US6194404 Process for the isolation of galanthamine |